Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Canaccord Genuity Reiterates Hold on Zimmer Biomet Holdings, Maintains $130 Price Target

Author: Benzinga Newsdesk | February 23, 2024 11:17am
Canaccord Genuity analyst Caitlin Cronin reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and maintains $130 price target.

Posted In: ZBH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist